NCT01488487: Everolimus and Pasireotide (SOM230) in Patients With Advanced or Metastatic Hepatocellular Carcinoma |
|
|
| Completed | 2 | 24 | US | Everolimus, Afinitor, RAD001, Pasireotide, SOM230, Pasireotide LAR, Pasireotide s.c. | UNC Lineberger Comprehensive Cancer Center, Novartis Pharmaceuticals | Advanced Adult Hepatocellular Carcinoma | 03/15 | 03/15 | | |